Trial Assessing News Today

28.07.2023 - MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE) - Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), (‘Incannex’ or the ‘Company’), is pleased to provide its quarterly activities report ...

Date: July 13, 2023 Public Announcement Incannex Receives HREC Approval for Phase...

Reliance on automated standing orders for prescribing primary prophylaxis colony-stimulating factor did not significantly impact its use.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Share this article Share this article NEW YORK, March 8, 2021 /PRNewswire/ -- The Alzheimers Drug Discovery Foundation (ADDF) announced today that four of its funded researchers will be making presentations at the 15 th International Conference on Alzheimers and Parkinsons Diseases (AD/PD™ 2021), which will be held virtually from Barcelona, Spain March 9-14, 2021. "The ADDF seeks out and maintains a diverse portfolio of novel drug and biomarker targets that reflect the many biological pathwa...

Press release content from PR Newswire. The AP news staff was not involved in its creation. ADDF-Funded Investigators to Present Findings at Next Week’s Conference on Alzheimer’s & Parkinson’s Diseases (AD/PD 21) March 8, 2021 GMT (PRNewsfoto/ADDF) NEW YORK, March 8, 2021 /PRNewswire/ -- The Alzheimer’s Drug Discovery Foundation (ADDF) announced today that four of its funded researchers will be making presentations at the 15th International Conference on Alzheimer’s and Parkinson’s ...